<DOC>
	<DOCNO>NCT02108301</DOCNO>
	<brief_summary>The aim present trial evaluate whether conversion immunosuppression tacrolimus cyclosporine A induces change ( ) hepatitis C-virus load , ( ii ) parameter hepatic function ( iii ) parameter glucose tolerance hepatitis C-positive renal transplant recipient .</brief_summary>
	<brief_title>Hepatitis C Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>write informed consent prior renal transplantation current tacrolimusbased immunosuppressive regimen hepatitis Cinfection age 1870 year current hemodialysis peritoneal dialysis pregnancy breastfeed know contraindication cyclosporine Atreatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>chronic hepatitis C-virus infection</keyword>
	<keyword>renal transplantation</keyword>
	<keyword>glucose tolerance</keyword>
	<keyword>immunosuppression</keyword>
</DOC>